The Scientist

» drug development, disease/medicine and culture

Most Recent

image: Techniques for Assessing Genomic Copy Number Variations

Techniques for Assessing Genomic Copy Number Variations

By | October 1, 2016

As the importance of genomic copy number variations for health and disease becomes clearer, researchers are creating new ways to detect these changes in the genome.

0 Comments

image: The Narcissistic Scientist

The Narcissistic Scientist

By | October 1, 2016

Are leading researchers driven more by the quest for knowledge or the pursuit of fame?

1 Comment

image: Thirty Years of Lab Safety

Thirty Years of Lab Safety

By | October 1, 2016

From mouth pipetting to automated liquid handling, life-science labs have gotten much safer over the past three decades.

1 Comment

image: Genes Linked to Dogs’ Sociability with People

Genes Linked to Dogs’ Sociability with People

By | September 30, 2016

Genetic variants on chromosome 26 appears to play a role in a dog’s tendency to turn to people for help.

0 Comments

image: Does Productivity Diminish Research Quality?

Does Productivity Diminish Research Quality?

By | September 28, 2016

More papers correlate with top-cited research for more-established academics, but not newly minted professors, according to a study.  

3 Comments

image: Broadly Neutralizing Antibodies in HIV Patients

Broadly Neutralizing Antibodies in HIV Patients

By | September 28, 2016

Researchers identify aspects of the patient, the virus, and the infection itself that influence whether a person with HIV will produce broadly neutralizing antibodies.

0 Comments

image: Q&A: From FDA to Industry

Q&A: From FDA to Industry

By | September 27, 2016

Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.

1 Comment

The National Institutes of Health is hosting a two-day conference on how the virus affects infants and children. The take-home message so far: microcephaly is but one of many potential problems for Zika-exposed fetuses.

0 Comments

image: Allergan’s Buying Spree Rolls On

Allergan’s Buying Spree Rolls On

By | September 21, 2016

The Ireland-based pharma company makes a $1.7 billion offer to acquire Tobira Therapeutics, a US firm developing liver disease drugs.

0 Comments

image: Feds Demand More Clinical Trial Reporting

Feds Demand More Clinical Trial Reporting

By | September 19, 2016

Expanded US Health and Human Services rules will require the results of more human studies to be made public.

1 Comment

Popular Now

  1. National Academies Detail the State of Weed Science
  2. Neural Mechanism Links Alcohol Consumption to Binge Eating
  3. Image of the Day: Monkey Business
    Image of the Day Image of the Day: Monkey Business

    For the first time, researchers have documented interspecies sexual behavior between a male Japanese macaque and a female sika deer.

  4. Do Preprints Belong in Grant Applications?
RayBiotech